Botanicals

Kratom, Explained: What It Is, the Risks, and the Legal Picture

Q: What kratom is Kratom (Mitragyna speciosa) is a Southeast Asian tree whose leaves contain more than 50 alkaloids. The two that matter most, mitragynine and 7-hydroxymitragynine (7-OH), bind to the brain’s mu-opioid receptors, the same targets as codeine and morphine. At low doses users report stimulant-like effects (energy, focus); higher doses are sedating and opioid-like (pain relief, euphoria). People use it for energy, pain, anxiety, or to self-manage opioid withdrawal. What the evidence and regulators say

This is where caution is essential. The U.S. FDA has warned for over a decade against using kratom, citing risks of liver toxicity, seizures, dependence, and death (FDA). Because the active alkaloids act on opioid receptors, regular use can cause tolerance, dependence, and an opioid-like withdrawal

Q: Legal status (2026)

Kratom is not a federally controlled substance - the DEA proposed scheduling it in 2016 but backed off after public pushback (Congressional Research Service). But it is banned in a handful of states (Alabama, Arkansas, Indiana, Vermont, Wisconsin, and several others, with the list changing and Washi

Kratom acts on the brain's opioid receptors. Here is an evidence-based look at how it works, the real safety concerns, and its shifting legal status.

Dr. Priya Nair · May 25, 2026 · 2 min read

Updated May 29, 2026

studies reviewed

2 min

reading time

Key Takeaways

Kratom binds opioid receptors — real addiction and withdrawal risk
FDA has not approved kratom for any use; legal status varies by state
Liver toxicity cases reported with heavy long-term use
Self-treating opioid withdrawal with kratom is dangerous without medical supervision

What kratom is

Kratom (Mitragyna speciosa) is a Southeast Asian tree whose leaves contain more than 50 alkaloids. The two that matter most, mitragynine and 7-hydroxymitragynine (7-OH), bind to the brain’s mu-opioid receptors, the same targets as codeine and morphine. At low doses users report stimulant-like effects (energy, focus); higher doses are sedating and opioid-like (pain relief, euphoria). People use it for energy, pain, anxiety, or to self-manage opioid withdrawal.

What the evidence and regulators say

This is where caution is essential. The U.S. FDA has warned for over a decade against using kratom, citing risks of liver toxicity, seizures, dependence, and death (FDA). Because the active alkaloids act on opioid receptors, regular use can cause tolerance, dependence, and an opioid-like withdrawal (anxiety, muscle aches, insomnia, diarrhea). A review of U.S. case reports catalogued serious acute harms including seizures and respiratory depression (Frontiers in Pharmacology, 2025), and poison-center calls have risen sharply over the past decade (The Conversation).

A particular concern is concentrated 7-OH products: 7-OH occurs only in trace amounts in the leaf but is far more potent at opioid receptors than morphine, and some manufacturers spike products with it.

Legal status (2026)

Kratom is not a federally controlled substance - the DEA proposed scheduling it in 2016 but backed off after public pushback (Congressional Research Service). But it is banned in a handful of states (Alabama, Arkansas, Indiana, Vermont, Wisconsin, and several others, with the list changing and Washington, D.C. added in 2025), while about 15 states have instead passed a Kratom Consumer Protection Act requiring age limits, lab testing, and honest labeling. Laws are changing fast, so verify your current state law before assuming it is legal.

Bottom line

Kratom sits in a genuine gray zone: legal in much of the U.S. and used by millions, but acting through the opioid system with real dependence and safety risks that regulators take seriously. If you are considering it, especially for pain or to manage withdrawal, treat it like the opioid-active substance it is and talk to a medical professional first.

This article is for general education and is not medical advice. Consult a qualified healthcare provider before using any substance, especially if you take medication or have a health condition.

Sources: FDA and Kratom | Acute adverse effects of kratom (Frontiers, 2025) | Kratom poisonings (The Conversation) | Kratom regulation (Congressional Research Service)

Dr. Priya Nair

MD, Integrative Medicine

A board-certified physician with dual training in internal medicine and integrative health, Priya spent a decade in patient care before transitioning to medical writing. She evaluates supplement research through a clinical lens.

Fact-checked by